Kriolen (Ambroxol Hydrochloride)

Ambroxol Hydrochloride reduces mucus viscosity by breaking down mucopolysaccharide fibers and stimulates surfactant production in the lungs. This dual action enhances mucociliary clearance, eases expectoration, and also provides local anti‑inflammatory and anesthetic effects that lessen cough irritation.

The appropriate dose of Kriolen is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of the condition, and renal function. Patients should follow the exact regimen provided by their prescriber and not adjust the dose on their own.

Safety data for Ambroxol Hydrochloride in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant. The prescriber will evaluate the individual situation before recommending therapy.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Kriolen. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kriolen’s active ingredient, Ambroxol Hydrochloride, offers both mucolytic and surfactant‑stimulating properties, which can provide faster mucus clearance compared with some older agents that act solely on viscosity. Its additional local anti‑inflammatory effect may also reduce cough irritation, making it a preferred option in many respiratory protocols.

Kriolen should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

Kriolen is taken orally, usually in tablet or liquid form, as directed by the prescriber. It should be swallowed with a glass of water, and dosing times may be spaced to align with meals or other medications as advised by the healthcare professional.

Serious adverse reactions, though rare, include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, difficulty breathing, or jaundice.

Kriolen is contraindicated in individuals with known hypersensitivity to Ambroxol Hydrochloride or any of its excipients. Caution is also advised for patients with severe renal impairment, uncontrolled asthma, or those who have experienced severe allergic reactions to mucolytic agents.